Evidence map›Paper›PMID 27595240›Full record

ArticleBritish journal of pharmacology2016

Adenosine A

Gibran Shaikh, Jin Zhang, Miguel Perez-Aso, Aranzazu Mediero, Bruce Cronstein

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. [Roles of interleukin-6/signal transduction and activator of transcription 3 pathway andZhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Adenosine AFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Gibran ShaikhDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
Jin ZhangDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
Miguel Perez-AsoDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
Aranzazu MedieroDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
Bruce CronsteinDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
New York University · USNingbo Medical Center Lihuili Hospital · CNUniversidad Autónoma de Madrid · ES

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
The Pharmacology of Dermal Fibrosis R01AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2018
$4.6M
The Pharmacology of Dermal FibrosisR56AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2014 to 2014
$373k
NCATS NIH HHS UL1 TR001445NIAMS NIH HHS R01 AR056672NIAMS NIH HHS R56 AR056672
6 · The paper itself

Abstract

background and purposeAdenosine A EXPERIMENTAL APPROACH: Total β-catenin, de-phosphorylated β-catenin (canonical activation, de-phospho β-catenin) and phosphorylated β-catenin at Ser KEY

resultsCGS21680 stimulation rapidly (15 min) increased cellular β-catenin levels. Both de-phospho β-catenin and p-Ser CONCLUSIONS AND IMPLICATIONS: A

Indexed as

AdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor Antagonistsbeta CateninBlotting, WesternCicatrixCollagen Type ICollagen Type IIIFibroblastsFibrosisGene Knockdown TechniquesHumansMicroscopy, FluorescencePhenethylaminesPhosphorylationReceptor, Adenosine A2A2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor Antagonistsbeta CateninCollagen Type ICollagen Type IIIPhenethylaminesReceptor, Adenosine A2ARNA, Small Interfering

Identifiers

PMID27595240
PMCPMC5738670
OpenAlexW2508740119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.